T-Therapeutics is a venture-backed company on a mission to unlock the power of T cells to treat chronic and infectious diseases.

Based on technology from Professor Allan Bradley’s laboratory in Cambridge University’s Department of Medicine, T-Therapeutics has secured significant investment from a blue-chip syndicate of investors to support its drug discovery efforts and prepare candidates for clinical development.

T-Therapeutics was founded in 2022, and we are at the very beginning of our journey to develop transformative T cell derived medicines. To realise our ambition, we are currently building facilities, recruiting staff, and establishing our research operations.

Biotechnology

Health Care

Life Sciences

Therapeutics

T-Therapeutics Ltd

T-Therapeutics Ltd's headquarters in Cambridge, United Kingdom

Jeffrey Hollins

Chris Herring

Alison Lloyd

Wei Wang

Frances Steward

Description

People (14)

Jeffrey Hollins

Frances Steward

Ilona Zvetkova

Nicholas Baldwin-Turner

Sulliman Ommar Omarjee, Ph D.

Luca Pellegrinet

Mike Jenns

Alison Lloyd

Wendy Bushell

Chris Herring

Ben Grimshaw

Qunwei Wang

Robert Tansley

Warren Hazelton

Jobs